PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
Rheumatoid arthritis (RA) is one of the most common and severe chronic inflammatory diseases. The paper reviews the recent studies evaluating the efficacy of rituximab (MabThera®), chimeric anti-CD20 monoclonal antibodies in B cells, in patients with RA. It has been shown that Rituximab is an extrem...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
IMA-PRESS LLC
2009-12-01
|
| Col·lecció: | Современная ревматология |
| Matèries: | |
| Accés en línia: | https://mrj.ima-press.net/mrj/article/view/261 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|